Category Archives: Science Research Technology

Science Research Technology

perma STAR VARIO Gen. 2.0

One lubrication system for all types of applications

perma STAR VARIO Gen. 2.0

perma STAR VARIO installed on an electric motor

Euerdorf, Germany – Lubrication plays an important role in maintenance programs. Equipment breakdowns caused by insufficient or incorrect lubrication can have fatal and costly consequences. In some cases they can even stop the entire production. Correct lubrication is therefore a basic requirement for trouble-free operation. The new perma STAR VARIO ensures optimum lubrication regardless of changing temperatures, high counter pressure, or contamination at the lubrication point.

The electromechanical lubrication system was invented 15 years ago and has proven itself in all kinds of industries. The new version offers many improvements: LCD-display with push button control, all around LED lights and a new design.

The LCD-display with push button control is self-explanatory and makes programming extremely simple. The all around LED signal offers visual control of the operating status even from a distance. The system assembles and installs in just minutes. With a pressure build-up of up to 6 bar it works reliably over a wide temperature range from -10 °C to +60 °C.

Fast, easy set up

perma STAR VARIO consists of a transparent LC unit filled with oil or grease, a powerful battery set, and a reusable drive unit. Just insert the battery, screw drive unit and LC unit together, push the button to enter the desired discharge period (1 – 12 months) and LC size (60, 120, 250 cm³) and the system is ready to go.

One lubrication system for all types of applications

perma STAR VARIO is suitable for indoor or outdoor applications with high or low ambient temperatures. The high pressure build-up to 6 bar makes it possible to install perma STAR VARIO at remote locations, away from dangerous areas, with extension tubes up to a length of 5 meters. Not only does this save time when the lubrication system is exchanged, but it also tremendously reduces the risk of workplace accidents. With its three different sizes and many possible settings, perma STAR VARIO is a preferred system for electric motors with very specific relubrication amounts. The all around LED signal light lets you monitor the operational status from a distance. The new design protects the drive unit from water and makes the system better suited for applications in moist and wet surroundings.

Environmentally friendly lubrication

perma STAR VARIO can be individually programmed to exactly meet the lubrication requirements of different applications. The system continuously discharges small lubricant amounts at specified intervals. This lowers lubricant consumption and prevents over-lubrication and lubricant spills. The reusable drive unit reduces maintenance costs and saves valuable resources. We are taking service a step further.

Our extensive perma accessory range includes connecting parts for just about all applications like electric motors, conveyor systems, pumps, fans and blowers. To make your start into perma automatic lubrication easier, we have developed special mounting sets. Our perma SELECT software helps you find the ideal lubrication system and the most suitable lubricant for your application. You can download it free of charge. Our team of lubrication experts will be glad to answer any questions, assist you with challenging applications, or visit you on site.

Technical data

Drive – reusable: Electromechanical
Power supply: TAR VARIO battery set 4.5 V
Discharge period: 1, 2, 3, … 12 months
Lubricant volume: 60 cm³, 120 cm³ or 250 cm³
Operating temperature: -10 °C to +60 °C
Pressure build-up: 6 bar
Protection class: IP 65
Lubricants: Oil / grease up to NLGI 2
Certifications: UL

perma-tec has been providing innovative and creative lubrication solutions for more than 50 years. Our single- and multi-point lubrication systems can be found in almost all types of industries and applications around the world.

perma-tec´s leadership in single-point lubrication is based on many patents and certifications. All perma products are developed, tested and manufactured in the company´s German headquarters and live up to the „Made in Germany“ quality.

With many years of experience and a network of subsidiaries and competent partners around the world we can offer our customers lubrication solutions that meet highest technical requirements.

Contact
perma-tec GmbH & Co. KG
Doris Bauer
Hammelburger Straße 21
97717 Euerdorf
Phone: +49 9704 609-3663
E-Mail: d.bauer@perma-tec.de
Url: http://www.perma-tec.com

Science Research Technology

BHS-Sonthofen: Mixers from Bavaria on the roof of the world

Mixing hydro dram concrete: Twin-shaft batch mixers deployed 3,700 m above sea level

BHS-Sonthofen: Mixers from Bavaria on the roof of the world

The six BHS-Sonthofen mixers are located in the building holding the batcher that feeds aggregates

Six twin-shaft batch mixers of type DKX 6.0 delivered by BHS-Sonthofen are producing the concrete needed to build the main embankment of the Dagu hydro dam undergoing construction near the Tibetan city of Zangmu. The construction site is located 3,700 m above sea level, making this the most elevated site ever for employing mixers from BHS. BHS-Sonthofen specially modified the mixers to meet the challenges they are facing at this extreme altitude.

The first two mixers of type DKX 6.0 started producing the first batches of concrete on 12 July 2017. Two months later, Sinohydro No. 9 Engineering Company commissioned four more units. The mixers will produce approximately three million tons of roller compacted concrete (RCC) over the course of the dam“s construction, which is scheduled for completion in 2019. The complete facility, which comprises six mixers, is dimensioned to produce 160,000 m³ of hardened concrete per month.

The mixers are equipped with a coarse-grain mixing unit for processing grain sizes up to 160 mm, as is typical in hydro dam construction. This mixer type has proven its worth in numerous installations across the globe.

About 6 m³ of hardened concrete are discharged per batch at a rate of up to 48 cycles per hour, resulting in a total yield of up to 288 m³ of hardened concrete in one hour. The cycle times are short due to the intensive mixing of the concrete and the extra-large rotary valves at the underside of the mixing trough, which significantly speed up the discharge process.

Given the vast amount of concrete that needs to be processed, BHS-Sonthofen reinforced the mixing troughs with a tougher version of its 28-mm „Optilong“ wear tiles. The service life of these tiles is nearly twice as long as the diamond-shaped tiles commonly used in construction projects. The variable hardness of the individual tile rows ensures uniform abrasion across all wear zones.

BHS-Sonthofen even accounted for the remote location of the construction site: In order to prepare the machines for a potentially unstable grid, the company used special motor couplings. The hydrodynamic turbo couplings reduce mechanical as well as electrical load peaks. Thanks to this property, they have proven ideal for use in locations with critical grid fluctuations.

Also, since high-altitude air does not extract as much heat from the electric motors, BHS-Sonthofen equipped the mixers with special motors that feature type „H“ insulation.

The sheer remoteness of the construction site posed yet another challenge. The construction site in Tibet is nearly 4,000 km from Tianjin near Beijing, which is where BHS-Sonthofen“s Chinese subsidiary is situated. It took 20 days to transport the mixers across this distance.

The project:

Once completed, the Dagu dam will be 126 m tall with a dam crest measuring 385 m. The power plant will generate 640 MW of hydro energy.

The dam is part of a major project undertaken by the Chinese government to provide the eastern parts of the Tibetan Autonomous Region with electricity, all the way to remote villages. Multiple hydro dams are damming up the Yarlung Tsangpo, the Earth“s highest river. It crosses Tibet from west to east and continues through India, where it is called Brahmaputra.

About BHS-Sonthofen GmbH

BHS-Sonthofen GmbH is an owner-operated group of companies in the field of machinery and plant engineering based in Sonthofen, Germany. The company offers technical solutions for mechanical process technology, concentrating primarily on mixing, crushing, recycling and filtration. BHS-Sonthofen has a global presence, with more than 350 employees and several subsidiaries.

The Mixing Technology division produces batch and continuous mixers and offers the full range of process technology services for mixing applications. The twin-shaft batch mixer, which is considered a global benchmark in the concrete industry, is a key product.

Building companies use the mixers first and foremost to produce transport, precast, high-performance and hydro dam concrete or concrete paving blocks. BHS mixers are also highly suited for mixing dry mortar, cement and sand-lime products or for processing clay-and-rock mixtures.

They are widely used for processing mineral mixes, landfill substances, fly ash, dusts or other bulk materials, or for the conditioning of sludges and the production of suspensions. The latter is often done in the context of backfilling mines or depositing mineral waste.

For further information, please visit: www.bhs-sonthofen.de

Company-Contact
BHS-Sonthofen GmbH
Roland Schmid
An der Eisenschmelze 47
D-87527 Sonthofen, Germany
Phone: +49 8321 6099-231
E-Mail: press@bhs-sonthofen.de
Url: http://www.bhs-sonthofen.de

Press
VIP Kommunikation
Regina Reinhardt
Dennewartstr. 25-27
52068 Aachen, Germany
Phone: +49.241.89468-24
Fax: +49.241.89468-44
E-Mail: reinhardt@vip-kommunikation.de
Url: http://www.vip-kommunikation.de

Science Research Technology

Emissions analysis for the highest demands

The increasing sense of environmental awareness around the globe is demanding higher standards for environmental monitoring.

Emissions analysis for the highest demands

NOx electrodeless discharge lamp

Heraeus Noblelight has developed an easy to use, plug & play light solution based on NOx light technology, for very accurate measurement of NOx and other pollution gases.

Environmental monitoring is used to describe the various processes, tests and investigations that are carried out in order to monitor the state of the environment and its changes, to understand and protect it. One of the major monitoring areas is air quality monitoring, which requires highly accurate measuring instruments. Heraeus Noblelight“s new light solution is developed for high accuracy, fast and real-time NOx measurement, together with very low operating costs.

The Heraeus plug & play light solution
NOx instrument development based on UV Resonance Absorption Spectroscopy (UV-RAS) has been difficult in the past, due to challenges in tuning the UV-lamp operation within its environment to optimize lifetime and intensity.

The NOx electrodeless discharge lamp (EDL) is a lamp with N2, O2 gas fill that emits a spectrum in the wavelength range between 200 nm to 600 nm. NOx-specific spectral lines in the 200 nm region can be used for the detection of NO and NO2, H2S, NH3, SO2 and other pollution gases.
Heraeus Noblelight“s new plug & play light solution for reliable NOx measurement is a lamp module that offers a pre-tuned UV-light source in a stable environment to ensure optimized performance. The NOx lamp module has an integrated EDL and comes with the corresponding power supply combined in a box. This makes integration into an OEM UV-RAS system very easy and cost efficient, plus light source replacement at End Of Life is by simply replacing the module in the field.

Fast and very accurate
High accuracy and stability are required in any measurement process. The new NOx module delivers both and even more. It is easy and effective in use, and without the need for consumables, it ensures very low operating costs. Enabling fast and accurate absorption measurements without cross-interference from water and CO2 , it saves time during the measurement process and makes dynamic (real time) measurements possible with high measurement confidence – a real competitive advantage for UV-RAS compared to other technologies.

Different methods to measure NOx
NOx is a generic term for the nitrogen oxides NO and NO2. It reacts in our atmosphere to form a wide variety of toxic products, as well as supporting the formation of ground-level (tropospheric) ozone.
Sources of NOx are predominantly man-made: burning fossil fuels for energy generation, such as coal-,oil- and gas-fired power stations, refuse incineration, some chemical processes and vehicle fuels, like modern diesel cars, used for land, water and air transportation.

Common methods for measuring NOx include sensor technologies based on chemiluminescence and electrochemical techniques.
This requires conversion of NO2 to NO for measurement or calculation of the NO2 content based on an assumed NO:NO2 ratio. In addition, NOx can be measured with infrared radiation, which can be affected by the content of H2O and CO2 in the sample. Direct UV absorption measurement of both NO and NO2 is the more precise way to measure total NOx for continuous emissions monitoring, and measurement in the UV-region avoids the influence of H2O and CO2.

Heraeus, the technology group headquartered in Hanau, Germany, is a leading international family-owned company formed in 1851. With expertise, a focus on innovations, operational excellence and an entrepreneurial leadership, we strive to continuously improve the businesses of our customers around the world.
We create high-quality solutions for our customers and strengthen their long-term competitiveness by combining material expertise with technological know-how. Our ideas are focused on important issues such as the environment, energy, health, mobility and industrial applications. Our portfolio ranges from components to coordinated material systems which are used in a wide variety of industries, including the steel, electronics, chemical, automotive and telecommunications industries.
In the 2016 financial year, Heraeus generated revenues without precious metals of EUR2.0 bn and a total revenue of EUR21.5 bn. With approximately 12,400 employees worldwide in more than 100 subsidiaries in 38 countries, Heraeus holds a leading position in its global markets.
In 2016, the Foundation for Family Businesses named Heraeus as one of the „Top 10 Family Businesses“ in Germany.
Heraeus Noblelight GmbH with its headquarters in Hanau and with subsidiaries in the USA, Great Britain, France and China is one of the technology- and market-leaders in the production of specialty light sources and systems. In 2016, Heraeus Noblelight employed 707 people worldwide. The organization develops, manufactures and markets infrared and ultraviolet emitters, systems and solutions for applications in industrial manufacture, environmental protection, medicine and cosmetics, research, development and analytical measurement techniques.

Contact
Heraeus Noblelight GmbH
Juliane Henze
Heraeusstraße 12-14
63450 Hanau
Phone: +49 (6181) 35-8539
E-Mail: juliane.henze@heraeus.com
Url: https://www.heraeus.com/en/hng/products_and_solutions/lamps_for_optics_and_analytics/nox_measurement.aspx

Science Research Technology

„A bridge between patients, medicine and research“

Retina Implant at DOG 2017 – PRO RETINA´s „International Retina Day“

"A bridge between patients, medicine and research"

(Source: Retina Implant AG)

(Reutlingen/Berlin) – Retina Implant AG showcased its product developments as part of the 115th DOG Conference of the German Society of Ophthalmology, which was held in Berlin from 28 September to 1 October 2017. The medtech company also collaborated with PRO RETINA Deutschland e.V. to mark the „International Retina Day“ at the annual conference on September 30. Self-help organisation PRO RETINA offered visually impaired people the chance to join its patient register for free on this day. The patient register is hugely important for research and treatment of rare congenital retinal conditions such as retinitis pigmentosa.

For 15 years, Retina Implant AG has been working intensively on researching and treating rare congenital retinal conditions. The medtech company was therefore keen to support the initiative of PRO RETINA Deutschland e.V, a self-help organisation by and for people with retinal degeneration, which opened its patient register free of charge to people affected by these conditions for one day only on 30 September, „International Retina Day“. „The patient register is neutral, independent and, of course, anonymous. It enables people with specific kinds of visual impairment to help develop studies, because researchers who are working on a study can contact PRO RETINA, and we will then contact the patients,“ explains Markus Georg, Managing Director of PRO RETINA Deutschland e.V. „This means we can actively support ophthalmology research, especially research into rare conditions such as retinitis pigmentosa. Our database forms a bridge between patients, medicine and research.“

The subretinal implant from Retina Implant AG can help visually impaired patients who perceive very little or no light as a result of various kinds of degenerative retinal diseases such as retinitis pigmentosa to regain a certain degree of useful sight. Most patients with an implanted chip can identify light sources, for example, which makes it easier for them to find their way around a room again. „Everyone with an interest in research and development in the field of degenerative retinal conditions will welcome this PRO RETINA campaign,“ explains Reinhard Rubow, CEO of Retina Implant AG. „The patient register is an important tool for bringing together patients, families, doctors and scientists with the aim of improving treatment for people with RP. This is our job, too, and that is why we welcome and support this initiative.“

On the day before the DOG Conference, PRO RETINA also organised a patient symposium on „Retinal degeneration – insights and outlooks“. This included a presentation by Prof. Florian Gekeler from the Eye Clinic at Katharinenhospital Stuttgart, in which he outlined various treatment options, from transcorneal electrical stimulation to retinal chips. The RETINA IMPLANT Alpha AMS subretinal chip was also the subject of a presentation at the DOG conference given by Dr. Katarina Stingl from the Tubingen Ophthalmology Research Institute. She presented the results of the latest study investigating the effectiveness of the retinal implant in 15 blind patients with congenital retinal degeneration (“ Efficacy of retina implant alpha AMS in 15 patients blind from inherited retinal degenerations„).

Contact form for the PRO RETINA Deutschland e.V. patient register:
http://www.pro-retina.de/forschungsfoerderung/patientenregister/formular

About Retina Implant AG
Retina Implant AG researches and develops innovative treatments and high-tech products for people suffering from retinitis pigmentosa (RP). The subretinal RETINA IMPLANT Alpha AMS can help blind patients regain a certain degree of useful sight. The CE-approved microchip is implanted beneath the retina (subretinally) at specialist RI implantation centres.
Transcorneal electrical stimulation (TES treatment) with the RI OkuStim® system offers RP patients with sufficient residual vision the opportunity to slow down the progression of the disease.
The company, based in Reutlingen, employs around 45 people and is managed by Reinhard Rubow (CEO and speaker of the Management Board), Jürgen Klein (Member of the Board, Sales & Marketing) and Dr. Alfred Stett (CTO, Member of the Board).

Company-Contact
Retina Implant AG
Ines Wülker
Gerhard-Kindler-Str. 13
72770 Reutlingen
Phone: + 49 71 21 3 64 03 – 289
E-Mail: ines.wuelker@retina-implant.de
Url: https://www.retina-implant.de/en/

Press
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70184 Stuttgart
Phone: 0711-60 70 719
E-Mail: info@zeeb.info
Url: http://www.zeeb-kommunikation.de

Science Research Technology

Artificial vision – successes and challenges

Retina Implant AG at „The Eye & The Chip“ research congress in Detroit, USA

Artificial vision - successes and challenges

(Source: Retina Implant AG)

(Reutlingen/Detroit) – Retina Implant AG was at „The Eye & The Chip – World Congress on Artificial Vision“ in Detroit, USA, to showcase research results relating to its subretinal implant. The annual congress is organised by the Detroit Institute of Ophthalmology, which is part of the Henry Ford Hospital. The event is a forum for interdisciplinary collaboration between specialists from across the world and focuses on advances in nanoelectronics and neurobiology that relate to „artificial vision“.

The subretinal implant from Retina Implant AG can help patients who perceive very little or no light as a result of the degenerative disease retinitis pigmentosa to regain a certain degree of useful sight. Most patients with an implanted chip can identify light sources, which makes it easier for them to find their way around a room again.

In his presentation at the congress, Dr. Alfred Stett, CTO of Retina Implant AG, described the design features of the subretinal implant to the assembled international specialists. The latest generation of the chip, the RETINA IMPLANT Alpha AMS, has virtually no externally visible electronic components. Only a small transponder that connects with the chip´s external power supply is embedded under the skin behind the ear. The chip is only around 12 square millimetres in size and is placed directly below the fovea centralis, which means it can move with the eye. This allows patients to use natural (previously learned) eye movement to locate objects.

Prof. Eberhart Zrenner, Senior Professor of Ophthalmology at the Werner Reichardt Centre for Integrative Neurosciences, which is part of the Institute for Ophthalmic Research at Eberhard Karls Universität Tübingen, presented the results of the latest clinical study ( „Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations„).

Dr. Günther Zeck from the Natural and Medical Sciences Institute (NMI) at the University of Tübingen gave a presentation entitled „Single-Pixel Stimulation of Blind Rodent Retina Using a Subretinal Implant“, in which he described how he uses the chip under laboratory conditions for his research into electrical stimulation of the retina.

The presentations, which covered the full spectrum from basic research and technology to clinical studies was debated intensively by the scientific community. „This congress brings together all the working groups around the world that are studying ´artificial vision using implants´,“ explained Dr. Stett. „Scientists, doctors, engineers and manufacturers report on their achievements – and the challenges that still need to be overcome.“ A great emphasis was placed on two key elements – firstly, the need for uniform test methods for measuring the quality of vision and, secondly, ensuring the effectiveness of the various treatment approaches can be compared. The congress delegates also agreed on the importance of applying strict selection criteria when determining which patients are suitable candidates for an implant and on the high value of intensive training after implantation.

About Retina Implant AG
Retina Implant AG researches and develops innovative treatments and high-tech products for people suffering from retinitis pigmentosa (RP). The subretinal RETINA IMPLANT Alpha AMS can help blind patients regain a certain degree of useful sight. The CE-approved microchip is implanted beneath the retina (subretinally) at specialist RI implantation centres.
Transcorneal electrical stimulation (TES treatment) with the RI OkuStim® system offers RP patients with sufficient residual vision the opportunity to slow down the progression of the disease.
The company, based in Reutlingen, employs around 45 people and is managed by Reinhard Rubow (CEO and speaker of the Management Board), Jürgen Klein (Member of the Board, Sales & Marketing) and Dr. Alfred Stett (CTO, Member of the Board).

Company-Contact
Retina Implant AG
Ines Wülker
Gerhard-Kindler-Str. 13
72770 Reutlingen
Phone: + 49 71 21 3 64 03 – 289
E-Mail: ines.wuelker@retina-implant.de
Url: http://implant.de

Press
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70184 Stuttgart
Phone: 0711-60 70 719
E-Mail: info@zeeb.info
Url: http://www.zeeb-kommunikation.de

Science Research Technology

PRO RETINA patient association recognises research into sub-retinal electronic implants

Retina Implant AG: Dr. Katarina Stingl wins Retinitis Pigmentosa Research Prize 2017

PRO RETINA patient association recognises research into sub-retinal electronic implants

Dr. Katarina Stingl (Source: Dr. Katarina Stingl)

(Reutlingen/Berlin) – This year´s Retinitis Pigmentosa Research Prize for preventing blindness, which is jointly awarded by the PRO RETINA Deutschland patient associations and Retina Suisse, was given to Dr. Katarina Stingl. The consultant ophthalmologist received the award during the 115th Congress of the German Society of Ophthalmology (DOG) in Berlin in recognition of two studies relating to sub-retinal electronic implants in patients with retinitis pigmentosa.

Prof. Eberhart Zrenner, Chairman of the Scientific and Medical Advisory Board of PRO RETINA Deutschland e.V., a self-help group by and for people with retinal degeneration, delivered the laudation and stressed that Dr. Stingl´s work makes her one of the most promising young scientists in the field of clinical experimental research into degenerative retinal conditions and their treatment. Dr. Stingl qualified as a university lecturer at Eberhard Karls University of Tübingen, in 2015, and has been working as a consultant for congenital retinal conditions in the ophthalmology department there since 2016.

Retina Implant AG feels that the scientific work of Dr. Stingl is of vital importance. We would like to congratulate her on this award, and thank her for her valuable scientific contribution,“ explains Reinhard Rubow, CEO of Retina Implant AG. „The Retinitis Pigmentosa Research Prize 2017 also motivates our employees to continue their intensive efforts in researching and treating rare congenital retinal conditions. PRO RETINA´s impetus and initiatives help shape the interaction between hospitals, patients and doctors – and that includes this prize. The PRO RETINA patient register was also launched at the DOG. This is hugely important for clinical research, and we hope that as many patients as possible will join the register so that future research such as that of Dr. Stingl will be of increasing benefit for all RP patients.“

Contact form for the PRO RETINA Deutschland e.V. patient register:
http://www.pro-retina.de/forschungsfoerderung/patientenregister/formular

About Retina Implant AG
Retina Implant AG researches and develops innovative treatments and high-tech products for people suffering from retinitis pigmentosa (RP). The subretinal RETINA IMPLANT Alpha AMS can help blind patients regain a certain degree of useful sight. The CE-approved microchip is implanted beneath the retina (subretinally) at specialist RI implantation centres.
Transcorneal electrical stimulation (TES treatment) with the RI OkuStim® system offers RP patients with sufficient residual vision the opportunity to slow down the progression of the disease.
The company, based in Reutlingen, employs around 45 people and is managed by Reinhard Rubow (CEO and speaker of the Management Board), Jürgen Klein (Member of the Board, Sales & Marketing) and Dr. Alfred Stett (CTO, Member of the Board).

Company-Contact
Retina Implant AG
Ines Wülker
Gerhard-Kindler-Str. 13
72770 Reutlingen
Phone: + 49 71 21 3 64 03 – 289
E-Mail: ines.wuelker@retina-implant.de
Url: http://implant.de

Press
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70184 Stuttgart
Phone: 0711-60 70 719
E-Mail: info@zeeb.info
Url: http://www.zeeb-kommunikation.de

Science Research Technology

Reimbursement of retinal implant for a limited number of patients

French health authority HAS approves Forfait Innovation application by Retina Implant AG

Reimbursement of retinal implant for a limited number of patients

(Source: Retina Implant AG)

(Reutlingen, Germany/Saint-Denis, France) – French health authority HAS (Haute Autorite de Sante) has just approved the Forfait Innovation application by Retina Implant AG to assess the benefits of its RETINA IMPLANT Alpha AMS subretinal implant. The procedure evaluates innovative technologies in the healthcare sector to quickly make them available to patients. As part of the Forfait Innovation process, over a two-year period the costs will be covered for the implant and treatment of a limited number of patients who perceive little or no light. Retina Implant AG fund the costs for the accompanying study, which is examining the impact of the implant on participants` daily lives (Impact on daily life of patients using the subretinal implant RETINA IMPLANT Alpha AMS).

Following the successful conclusion of the study, the implant will be added to the list of approved services of health insurance companies in France. As a result of the reimbursement, an innovative technology can be made available to patients with the hereditary retinal disease retinitis pigmentosa (RP), which leads to total blindness in the final stage. Although RP is a rare disease, some 130,000 people suffer from it in Europe alone. The subretinal implant is virtually invisible except for a small transponder fixed behind the ear. The implant can partially restore the sight of blind people suffering from RP. This means a large proportion of patients can make out light sources with the RETINA IMPLANT Alpha AMS and thus find their way around a room, for example.

„For some time now, work has been in progress to focus attention on the practical benefits for visually impaired people in their everyday lives, alongside standard sight measurements. We`re delighted this study is taking particular account of this aspect,“ explains Jürgen Klein, Sales and Marketing Director at Retina Implant AG. „France is therefore taking a leading role in Europe in evaluating subretinal implants.“ The study will be performed in close cooperation between the university hospital CHU Montpellier for screening and patient follow-up and the implantation centre Clinique St Jean in Montpellier for the surgery, with further centres planned.

About Retina Implant AG
Retina Implant AG researches and develops innovative treatments and high-tech products for people suffering from retinitis pigmentosa (RP). The subretinal RETINA IMPLANT Alpha AMS can help blind patients regain a certain degree of useful sight. The CE-approved microchip is implanted beneath the retina (subretinally) at specialist RI implantation centres.
Transcorneal electrical stimulation (TES treatment) with the RI OkuStim® system offers RP patients with sufficient residual vision the opportunity to slow down the progression of the disease.
The company, based in Reutlingen, employs around 45 people and is managed by Reinhard Rubow (CEO and speaker of the Management Board), Jürgen Klein (Member of the Board, Sales & Marketing) and Dr. Alfred Stett (CTO, Member of the Board).

Company-Contact
Retina Implant AG
Ines Wülker
Gerhard-Kindler-Str. 13
72770 Reutlingen
Phone: + 49 71 21 3 64 03 – 289
E-Mail: ines.wuelker@retina-implant.de
Url: http://implant.de

Press
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70184 Stuttgart
Phone: 0711-60 70 719
E-Mail: info@zeeb.info
Url: http://www.zeeb-kommunikation.de

Science Research Technology

Great Success: AIRTEC 2017 – Now only 10 minutes from the Munich Airport

September 26, 2017. The organizers of AIRTEC 2017 have succeeded to organize AIRTEC 2017 at the Munich Airport Business Park, Hallbergmoos, only 10 minutes from the international Airport Munich, Germany. Due to an unanimous decision of the Munich Airport municipal council Hallbergmoos on September 5th, 2017, they voted for AIRTEC 2017 to be organized at Munich Airport, Hallbergmoos. The Deputy Mayor declared this at the AIRTEC Board Meeting on September 7th and highlighted the importance of AIRTEC for this region. This is an outstanding milestone for the success of AIRTEC. It is unique in Germany, that one of the most significant international aerospace exhibitions and conferences, the 12th AIRTEC takes place from October 24th until 26th, 2017 at one of the major international Airports in Europe, the Munich Airport, Germany. Additionally the region Munich Airport, Hallbergmoos, is an increasing and very innovative high tech location with the establishment of international aerospace and high tech companies. Also for these reasons, AIRTEC fits ideally to the Munich Airport area. It has always been the ultimate target to organize AIRTEC as close as possible to the international Airport Munich, Germany.

The reasons for this are evident:

Exhibitors and visitors should have comfortable, time-saving and efficient logistics as possible at AIRTEC 2017. The high international participation of AIRTEC, which is of major importance for the success of an international aerospace event, will be even more increased being so close to the international Airport Munich. The B2B meetings, the heart of AIRTEC, can take place in 2017 more smoothly. International procurement-, supply chain- and technology managers can reach AIRTEC 2017 from world-wide easily and fast. Efficient parking space is offered near the entrance of the exhibition area. A shuttle service from the subway station Airport and Hallbergmoos is available.

This year, AIRTEC 2017 is more international and innovative as ever. Exhibitors from all over Europe, China, India, Israel, Pakistan, South Africa and the United States are represented. Amongst them are leading companies from the aerospace industry and world-wide leading technology enterprises. In the international Exhibition Board are amongst others represented companies like Bosch Rexroth, Latecoere Interconnection Systems, OHB System, Pratt & Whitney and Siemens. At the international conference are renowned experts from industry and research from five continents. AIRTEC 2017 is inaugurated by Dr. Sebastiano Fumero, Head of Unit, DG Research & Innovation, H3 Aviation at the European Commission, Brigitte Zypries, Federal Minister for Economic Affairs and Energy and Federal Government Coordinator of German Aerospace Policy and Richard Aboulafia, Vice President, Analysis at Teal Group Corp.

About Euromold
Euromold is the world’s leading trade fair for mold-making, tooling, design, additive manufacturing and product development. Based on the process chain „from design to prototype to series“, it presents products and services, technologies and innovations, and trends for the markets of the future. The Euromold process chain promotes the formation of networks, partnerships and business relationships. Euromold offers a unique trade fair concept that closes the gap between industrial designers, product developers, fabricators, suppliers and users. The Euromold trade fair reveals methods for faster, more cost-effective and efficient development and manufacturing of new products. This increasingly plays a central role in the modern economy.

Contact
AIRTEC GmbH & Co. KG
Diana Schnabel
P.O. Box 700164
60551 Frankfurt / Main
Phone: +49 (0) 69 27 40 03–54
E-Mail: airtec@airtec.aero
Url: http://www.airtec.aero

Science Research Technology

Initial results of RETINA IMPLANT Alpha AMS trial published

New study on functionality of Retina Implant AG´s subretinal implant in Frontiers in Neuroscience

Initial results of RETINA IMPLANT Alpha AMS trial published

(Source: Retina Implant AG)

(Reutlingen) – The scientific journal Frontiers in Neuroscience has published a report on the functionality of Retina Implant AG´s RETINA IMPLANT Alpha AMS subretinal implant. The joint article by a group of experts headed by Eberhart Zrenner, Senior Professor of Ophthalmology at the Werner Reichardt Centre for Integrative Neuroscience, which forms part of the Institute for Ophthalmic Research at the Eberhard Karls University of Tübingen, relates to clinical experience with a group of patients who had the latest version of the chip implanted at various hospitals in Europe.

In the article, entitled „Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations“, lead author Dr.Katharina Stingl from the Tübingen Institute for Ophthalmic Research and other doctors and scientists involved in the trial describe how the chip performed.

Study:
Stingl K., Schippert R., Bartz-Schmidt K. U., Besch D., Cottriall C. L., Edwards T. L., Gekeler F., Greppmaier U., Kiel K., Koitschev A., Kühlewein L., MacLaren R. E., Ramsden J. D., Roider J., Rothermel A., Sachs H., Schröder G. S., Tode J., Troelenberg N. and Zrenner E. (2017): Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations. Frontiers in Neuroscience. 11:445. doi: 10.3389/ fnins.2017.00445.
http://journal.frontiersin.org/article/10.3389/fnins.2017.00445/full

About Retina Implant AG
Retina Implant AG researches and develops innovative treatments and high-tech products for people suffering from retinitis pigmentosa (RP). The subretinal RETINA IMPLANT Alpha AMS can help blind patients regain a certain degree of useful sight. The CE-approved microchip is implanted beneath the retina (subretinally) at specialist RI implantation centres.
Transcorneal electrical stimulation (TES treatment) with the RI OkuStim® system offers RP patients with sufficient residual vision the opportunity to slow down the progression of the dis-ease.
The company, based in Reutlingen, employs around 45 people and is managed by Reinhard Rubow (CEO and speaker of the Management Board), Jürgen Klein (Member ot the Board, Sales & Marketing) and Dr. Alfred Stett (CTO, Member of the Board).

Company-Contact
Retina Implant AG
Ines Wülker
Gerhard-Kindler-Str. 13
72770 Reutlingen
Phone: + 49 71 21 3 64 03 – 289
E-Mail: ines.wuelker@retina-implant.de
Url: http://implant.de

Press
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70184 Stuttgart
Phone: 0711-60 70 719
E-Mail: info@zeeb.info
Url: http://www.zeeb-kommunikation.de

Science Research Technology

Surgeons only have two hands too

„Incisions and insights“ – medtech engineers and medical practitioners in dialogue at abdominal surgery workshop

Surgeons only have two hands too

„Incisions and insights“ workshop, which focused on abdominal surgery (Source: BioRegio STERN/Michael Latz)

(Stuttgart/Tübingen) – Once again, the Stuttgart and Tübingen Inter-University Centre for Medical Technology (IZST) and the Verein zur Förderung der Biotechnologie und Medizintechnik e. V. (Society for the Promotion of Biotechnology and Medical Technology) in conjunction with BioRegio STERN Management GmbH played host to developers from medtech companies at the „Incisions and insights“ workshop. The event, which focused on abdominal surgery, adopted an interdisciplinary approach and brought together disciplines such as general, visceral, transplant and paediatric surgery, paediatric urology, clinical anatomy and cell analysis, diagnostic and interventional radiology, thoracic and cardiovascular surgery, urology and gynaecology.

With live streaming of surgery and practical exercises in the clinical anatomy operating theatre, the „Incisions and insights“ event is anything other than ordinary. To highlight typical operating theatre problems to developers from medtech companies and work with them to look for solutions, a total of six medical directors from the University Hospital of Tübingen discussed the issues at the operating table with the invited specialists – Prof. Jörg Fuchs, Medical Director of Paediatric Surgery and Paediatric Urology, Prof. Alfred Königsrainer, Medical Director of General, Visceral and Transplant Surgery, Prof. Christian Schlensak, Medical Director of Thoracic and Cardiovascular Surgery, Prof. Arnulf Stenzl, Medical Director of Urology, Prof. Bernhard Krämer, Deputy Medical Director of Gynaecology, and Prof. Fabian Bamberg, Deputy Medical Director of Diagnostic and Interventional Radiology. Prof. Bernhard Hirt, Director of the Institute of Clinical Anatomy and Cell Analysis at the University of Tübingen, hosted and chaired the workshop and welcomed the numerous guests in the auditorium and the students and medical practitioners linked via live stream with this statement of principle: „We aren“t showing you the perfect operation and anatomy – instead, we’re showing you the real challenges.“

Surgeons only have two hands too
The reality of intraperitoneal surgery in the abdominal structure covered by the peritoneum and in the retroperitoneum, the region behind the peritoneum and the abdomen itself, includes the need for retractors which keep the operating area open to remove a tumour in the kidneys or ovaries, for example. The surgeons` wish list for this standard medtech instrument was amazingly long. The retractors should be more adjustable to enable the position to be changed more easily during an operation. They should not be made only of metal, as this may damage tissue, but should instead be manufactured from softer materials. They should be translucent, provide a source of light themselves and have additional analysis functions. A surgeon summed up the demands in the following words: „We actually need eight hands. Multifunctional refractors would be better than assistants, who may get in the way in some circumstances.“

It’s dark down there
Two consultants demonstrated a „live“ incision of an abdomen and the use of retractors in the Anatomy operating theatre in order to highlight the next challenge – „it’s dark down there,“ as one of them put it, summing up the problem of visualisation and lighting. The solution from the consultants“ perspective? The lighting should be combined with a camera system so that everyone involved in an operation has the same view of the patient. The camera should be able to follow the surgeon’s hand automatically. It would be best if loupes and headlights were combined into one small, lightweight system with a camera using chip technology. As in the first workshop, a clear desire was expressed for a tablet solution to visualise the operating theatre scenario so that surgeons do not need to turn to look at monitors during surgery: „The surgeon’s view of the abdomen should be transmitted directly to an iPad placed right next to the incision,“ said Prof. Stenzl in a call to the developers and other guests.

Small instruments, patients too large – small patients, instruments too large
On one hand, instruments for minimally invasive operations, such as laparoscopy, are set to become increasingly smaller. On the other hand, patients in Central Europe are becoming more and more obese, and there is a lack of instruments that can be adjusted in size. The medtech sector also faces unresolved challenges for the smallest patients, as Prof. Fuchs regretted: „Unfortunately, no miniaturised instruments are available for minimally invasive surgery for babies. A lot still needs to be done in this area.“

Intelligent patching. Stitching that takes care of itself
Yet surgeons aren’t just looking for innovations for instruments but also for materials. While patches for closing arteries have for decades been made of synthetics, for a long time now intensive research has been carried out into tissue engineering solutions to biologise materials. Closing and, in particular, stitching are a genuinely controversial issue for surgeons. Ligatures, shutting off vessels etc., have to be performed under extremely difficult conditions in terms of light and the position in the abdomen. For the patient, it is essential that stitches are secure. The medtech engineers were thus called upon to look for alternatives to traditional vascular suture.

The medtech engineers and medical professionals therefore had much to discuss at the operating tables in Anatomy. „Once again, we struck a chord with this workshop,“ said a delighted Dr. Klaus Eichenberg, co-organiser and Managing Director of BioRegio STERN Management GmbH. „Following the first event last year, concrete development projects have already been initiated at medtech companies. And I’m confident that head and throat surgery will also provide inspiration for new ideas among developers in the year ahead.“

About BioRegio STERN Management GmbH:
BioRegio STERN Management GmbH is a skill-sharing network, providing a help and ad-vice centre for founders of new businesses, entrepreneurs and researchers in the life sciences sector in the cities of Stuttgart, Tübingen, Esslingen and Reutlingen and the Stuttgart and Neckar-Alb regions. BioRegio STERN Management GmbH represents the interests of these market players in dealings with political circles, the media and associations and provides advice on grant applications and corporate financing. Key focal points include regenerative medicine, medical technology and the automation of biotechnology. Managing Director Dr. Klaus Eichenberg is a molecular and cell biologist and investment analyst.

Company-Contact
BioRegio STERN Management GmbH
Klaus Eichenberg
Friedrichstrasse 10
70174 Stuttgart
Phone: +49 (0)711-870354-0
E-Mail: info@bioregio-stern.de
Url: http://www.bioregio-stern.de/en

Press
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70174 Stuttgart
Phone: +49 (0)711-6070719
E-Mail: info@zeeb.info
Url: http://www.zeeb.info